Blood cancer Clinical Trials in Richmond, VA
As of September 2026, 38 paid clinical trials are recruiting for Blood cancer in Richmond, Virginia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
38 clinical trials for Blood cancer
·Clear filters·A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Project: Every Child for Younger Patients With Cancer
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Top Research Study Locations in Richmond
Researchers run research studies in Richmond, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Virginia Commonwealth University | Heart Failure, Myotonic Dystrophy 1, Violence | 157 |
| VCU Massey Comprehensive Cancer Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8 | 107 |
| VCU Massey Cancer Center at Stony Point | Anatomic Stage II Breast Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 51 |
| Virginia Cancer Institute | Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Anatomic Stage I Breast Cancer AJCC v8 | 23 |
| Bon Secours Saint Mary's Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 22 |
| Bon Secours Cancer Institute at Reynolds Crossing | Stage IVA Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8 | 17 |
| Clinical Research Partners, LLC | Overweight, Pneumococcal Disease, Adult | 14 |
| Bon Secours Richmond Community Hospital | Breast Cancer, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 11 |
| GSK Investigational Site | Chickenpox, Colonic Neoplasms, Influenza, Human | 9 |
| VCU Medical Center | Acute Decompensated Heart Failure, Chemotherapy Induced Peripheral Neuropathy (CIPN), Chronic Thromboembolic Pulmonary Hypertension | 9 |
| Virginia Commonwealth University Massey Cancer Center | B-cell Malignancy, Cervical Cancer, Chemotherapy-induced Peripheral Neuropathy | 9 |
| Richmond VA Medical Center | Colorectal Neoplasms, Dementia Alzheimer Type, Dementia Associated With Cerebrovascular Disease | 7 |
| Virginia Commonwealth University Medical Center | Adolescent - Emotional Problem, Bipolar Disorder, Bipolar I Disorder | 7 |
| Hunter Holmes McGuire VA Medical Center, Richmond, VA | Acute Kidney Injury, Atherosclerosis, Cardiovascular Disease | 6 |
| Richmond VA Medical Center, Richmond, VA | Alcohol Use Disorder (AUD), Cirrhosis, Epilepsy | 6 |
| OvationLab | Gastrointestinal, Biological Aging, Detoxification | 5 |
| Virginia Commonwealth University/Massey Cancer Center | Stage IVB Prostate Cancer AJCC v8, Breast Carcinoma, Castration Levels of Testosterone | 5 |
| VCU Massey Cancer Center | Cutaneous Melanoma, Stage II, Metastatic Head-and-neck Squamous-cell Carcinoma, Non-small Cell Lung Cancer | 5 |
| Clinical Trial Site | Advanced Hepatocellular Carcinoma, High Cardiovascular Risk, High Risk Cardiovascular Disease | 4 |
| Children's Hospital of Richmond at VCU | Becker Muscular Dystrophy, Cardiac Arrest, Cardiac Arrest (CA) | 4 |
| Henrico Doctor's Hospital | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma | 4 |
| National Clin Res Inc. | Obesity, Overweight, Diabetes Mellitus | 4 |
| Pulmonary Associates of Richmond, Inc. | Interstitial Lung Disease, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis | 4 |
| Chippenham Hospital | Hypertension, Lumbar Spinal Stenosis, Percutaneous Coronary Intervention | 3 |
| Dominion Medical Associates | Cardiovascular Disease and Lipoprotein(a), Cardiovascular Risk, Hypercholesterolaemia | 3 |
Active & Upcoming Studies in Richmond (2026)
Recruiting trials in Richmond grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (208 active studies)
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma · Phase 3 · AbbVie
- Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · Virginia Commonwealth University
Cardiovascular (43 active studies)
- CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA) · VA Office of Research and Development
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Diabetes & metabolic (26 active studies)
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS) · Phase 3 · Eli Lilly and Company
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
Neurology & pain (18 active studies)
- Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury · Virginia Commonwealth University
- Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD) · Virginia Commonwealth University
Mental health & behavior (15 active studies)
- QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360) · Veterans Recovery Network Inc.
- Enhancing Addiction Treatment Through Psychoeducation · Virginia Commonwealth University
Vaccines (8 active studies)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age · Phase 2 · ModernaTX, Inc.
Pediatric (5 active studies)
- Children's Bipolar Network Treatment Trial I · University of California, Los Angeles
- Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS · Phase 2, Phase 3 · Nationwide Children's Hospital
HIV / STI (4 active studies)
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV · Phase 2 · Naga P. Chalasani
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection · Phase 1 · GigaGen, Inc.
Eye & vision (1 active study)
Common conditions studied in Richmond
- Heart Failure (11 active studies)
- Obesity (11 active studies)
- Breast Cancer (10 active studies)
- Acute Myeloid Leukemia (9 active studies)
- Overweight (8 active studies)
- Malignant Solid Neoplasm (7 active studies)
Leading research sponsors in Richmond
- Virginia Commonwealth University
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Richmond?
There are approximately 580 recruiting clinical trials in Richmond, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Richmond pay participants?
Most recruiting trials in Richmond compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Richmond?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Richmond?
The most common conditions under active study in Richmond include Heart Failure (11), Obesity (11), Breast Cancer (10), Acute Myeloid Leukemia (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Richmond?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Richmond on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Richmond?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Richmond?
Recruiting research sites in Richmond include Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, VCU Massey Cancer Center at Stony Point, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Richmond right now?
The largest active categories in Richmond are Cancer & tumors (208), Cardiovascular (43), Diabetes & metabolic (26). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.